Allerderm Report issue

For profit Phase 2 Phase 4
Founded: Mill Valley CA United States (1980)
Status: Acquired by Virbac (1987)

Organization Overview

First Clinical Trial
2012
NCT01798589
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Allerderm | Allerderm (dba SmartPractice)

Active Ingredients

Drugs in Phase 4 Trials (1)

ethylenediamine (1 trial)

Drugs in Phase 2 Trials (5)

aluminum (1 trial)

Hydroxymethylpentylcyclohexenecarboxaldehyde (lyral) (1 trial)

mercury (1 trial)

metal allergen (1 trial)

palladium (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dermatitis (Phase 4)

Dermatitis, Allergic Contact (Phase 4)

Dermatitis, Contact (Phase 4)

Eczema (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 6